<code id='7227E53FFA'></code><style id='7227E53FFA'></style>
    • <acronym id='7227E53FFA'></acronym>
      <center id='7227E53FFA'><center id='7227E53FFA'><tfoot id='7227E53FFA'></tfoot></center><abbr id='7227E53FFA'><dir id='7227E53FFA'><tfoot id='7227E53FFA'></tfoot><noframes id='7227E53FFA'>

    • <optgroup id='7227E53FFA'><strike id='7227E53FFA'><sup id='7227E53FFA'></sup></strike><code id='7227E53FFA'></code></optgroup>
        1. <b id='7227E53FFA'><label id='7227E53FFA'><select id='7227E53FFA'><dt id='7227E53FFA'><span id='7227E53FFA'></span></dt></select></label></b><u id='7227E53FFA'></u>
          <i id='7227E53FFA'><strike id='7227E53FFA'><tt id='7227E53FFA'><pre id='7227E53FFA'></pre></tt></strike></i>

          fashion

          fashion

          author:focus    Page View:8132
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Study: Why relieving medical debt did not improve financial outcomes
          Study: Why relieving medical debt did not improve financial outcomes

          AdobePhilanthropistsandfoundationsliketheoneIworkfortakealotofcalculatedrisks.Weinvestinresearch,adv

          read more
          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more

          Pharma companies must ensure equitable access to obesity drugs

          TheobesitydrugWegovyisseenatapharmacyinChicago.ScottOlson/GettyImagesWeightlosstreatmentshavethepote